|
|
Volumn 1, Issue 7, 2010, Pages 466-469
|
|
Beta-adrenergic signaling, a novel target for cancer therapy?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BETA ADRENERGIC RECEPTOR;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
PROPRANOLOL;
BREAST TUMOR;
CARCINOMA;
DRUG EFFECT;
EVALUATION;
FEMALE;
HUMAN;
HYPERTENSION;
METABOLISM;
METASTASIS;
METHODOLOGY;
MOLECULARLY TARGETED THERAPY;
MORTALITY;
NEOPLASM;
NOTE;
PATHOLOGY;
PHYSIOLOGY;
SIGNAL TRANSDUCTION;
SURVIVAL;
ADRENERGIC BETA-ANTAGONISTS;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
CARCINOMA;
FEMALE;
HUMANS;
HYPERTENSION;
MOLECULAR TARGETED THERAPY;
NEOPLASM METASTASIS;
NEOPLASMS;
PROPRANOLOL;
RECEPTORS, ADRENERGIC, BETA;
SIGNAL TRANSDUCTION;
SURVIVAL ANALYSIS;
|
|
EID: 79953647658
PISSN: None
EISSN: 19492553
Source Type: Journal
DOI: 10.18632/oncotarget.182 Document Type: Note |
|
Times cited : (58)
|
|
References (0)
|
